{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T20:20:09Z","timestamp":1766780409227,"version":"3.48.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"DOI":"10.7759\/cureus.100141","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T20:15:31Z","timestamp":1766780131000},"source":"Crossref","is-referenced-by-count":0,"title":["High Mortality in the Male Breast Cancer Community: A Report on Its Drivers and a Demand for Change in Healthcare Policy"],"prefix":"10.7759","author":[{"given":"Srikavya","family":"Pasumarthy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheri","family":"Ambrose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Washburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lopamudra","family":"Das Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Key statistics for breast cancer. (2025). Accessed. December 11, 2025: https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/about\/how-common-is-breast-cancer.html."},{"key":"ref2","unstructured":"Key statistics for breast cancer in men. (2025). Accessed. December 11, 2025: https:\/\/www.cancer.org\/cancer\/types\/breast-cancer-in-men\/key-statistics.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm203","article-title":"Breast cancer risk among male BRCA1 and BRCA2 mutation carriers","volume":"99","author":"Tai YC","year":"2007","unstructured":"Tai YC, Domchek S, Parmigiani G, Chen S. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2007, 99:1811-4. 10.1093\/jnci\/djm203","journal-title":"J Natl Cancer Inst"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen S","year":"2007","unstructured":"Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007, 25:1329-33. 10.1200\/JCO.2006.09.1066","journal-title":"J Clin Oncol"},{"key":"ref5","unstructured":"Hormone receptor-positive (HR+) breast cancer. (2025). Accessed. December 11, 2025: https:\/\/www.pennmedicine.org\/cancer\/types-of-cancer\/breast-cancer\/types-of-breast-cancer\/hormone-positive-breast-canc...."},{"key":"ref6","unstructured":"Breast cancer HER2 status. (2025). Accessed. December 11, 2025: https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/understanding-a-breast-cancer-diagnosis\/breast-cancer-her2-status.html."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91131-4","article-title":"Comparison between male and female breast cancer survival using propensity score matching analysis","volume":"11","author":"Scomersi S","year":"2021","unstructured":"Scomersi S, Giudici F, Cacciatore G, et al.. Comparison between male and female breast cancer survival using propensity score matching analysis. Sci Rep. 2021, 11:11639. 10.1038\/s41598-021-91131-4","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2016.02.017","article-title":"Male breast cancer is not congruent with the female disease","volume":"101","author":"Fentiman IS","year":"2016","unstructured":"Fentiman IS. Male breast cancer is not congruent with the female disease. Crit Rev Oncol Hematol. 2016, 101:119-24. 10.1016\/j.critrevonc.2016.02.017","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2539-7","article-title":"Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer","volume":"144","author":"Eggemann H","year":"2018","unstructured":"Eggemann H, Altmann U, Costa SD, Ignatov A. Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer. J Cancer Res Clin Oncol. 2018, 144:337-41. 10.1007\/s00432-017-2539-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0857-z","article-title":"Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis","volume":"123","author":"Eggemann H","year":"2020","unstructured":"Eggemann H, Brucker C, Schrauder M, et al.. Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis. Br J Cancer. 2020, 123:33-7. 10.1038\/s41416-020-0857-z","journal-title":"Br J Cancer"},{"key":"ref11","unstructured":"Breast Cancer Hub (BCH) clinical data analysis study - male breast cancer. (2025). Accessed. December 11, 2025: https:\/\/www.breastcancerhub.org\/male-bc."},{"key":"ref12","unstructured":"All cancer sites combined. recent trends in SEER age-adjusted incidence rates, 2000-2022. (2025). Accessed: December 11, 2025: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38183","article-title":"Male and female disparities in breast cancer epidemiology: a comparative cross-sectional analysis of a Brazilian cohort (2017-2021)","volume":"10","author":"Antonini M","year":"2024","unstructured":"Antonini M, Mattar A, Pannain GD, et al.. Male and female disparities in breast cancer epidemiology: a comparative cross-sectional analysis of a Brazilian cohort (2017-2021). Heliyon. 2024, 10:e38183. 10.1016\/j.heliyon.2024.e38183","journal-title":"Heliyon"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.SABCS-09-2075","article-title":"Male breast cancer: a population-based comparison with female breast cancer","volume":"69","author":"Anderson WF","year":"2009","unstructured":"Anderson WF, Jatoi I, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. Cancer Res. 2009, 69:2075. 10.1158\/0008-5472.SABCS-09-2075","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly MB","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, et al.. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021, 19:77-102. 10.6004\/jnccn.2021.0001","journal-title":"J Natl Compr Canc Netw"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki Y","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, et al.. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994, 266:66-71. 10.1126\/science.7545954","journal-title":"Science"},{"key":"ref17","unstructured":"Billions left behind on the path to universal health coverage. (2023). Accessed. December 11, 2025: http:\/\/extranet.who.int\/uhcpartnership\/news\/billions-left-behind-path-universal-health-coverage?utm_source=chatgpt.com."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/npre.2008.2632.1","article-title":"Breast cancer associated metastasis is significantly increased in a model of autoimmune arthritis","volume":"0","author":"Das Roy L","year":"2008","unstructured":"Das Roy L, Pathangey L, Tinder T, Mukherjee P. Breast cancer associated metastasis is significantly increased in a model of autoimmune arthritis. Nat Prec. 2008, 0:0. 10.1038\/npre.2008.2632.1","journal-title":"Nat Prec"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2345","article-title":"Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis","volume":"11","author":"Das Roy L","year":"2009","unstructured":"Das Roy L, Pathangey LB, Tinder TL, Schettini JL, Gruber HE, Mukherjee P. Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Res. 2009, 11:R56.","journal-title":"Breast Cancer Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-365","article-title":"Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer","volume":"11","author":"Das Roy LD","year":"2011","unstructured":"Das Roy LD, Ghosh S, Pathangey LB, Tinder TL, Gruber HE, Mukherjee P. Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer. BMC Cancer. 2011, 11:365. 10.1186\/1471-2407-11-365","journal-title":"BMC Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3412","article-title":"Arthritis augments breast cancer metastasis: role of mast cells and SCF\/c-Kit signaling","volume":"15","author":"Das Roy L","year":"2013","unstructured":"Das Roy L, Curry JM, Sahraei M, Besmer DM, Kidiyoor A, Gruber HE, Mukherjee P. Arthritis augments breast cancer metastasis: role of mast cells and SCF\/c-Kit signaling. Breast Cancer Res. 2013, 15:R32. 10.1186\/bcr3412","journal-title":"Breast Cancer Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-225","article-title":"Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12\/SDF-1 expression in the metastatic niches","volume":"14","author":"Roy LD","year":"2014","unstructured":"Roy LD, Sahraei M, Schettini JL, Gruber HE, Besmer DM, Mukherjee P. Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12\/SDF-1 expression in the metastatic niches. BMC Cancer. 2014, 14:225. 10.1186\/1471-2407-14-225","journal-title":"BMC Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/339820-high-mortality-in-the-male-breast-cancer-community-a-report-on-its-drivers-and-a-demand-for-change-in-healthcare-policy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T20:15:33Z","timestamp":1766780133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/339820-high-mortality-in-the-male-breast-cancer-community-a-report-on-its-drivers-and-a-demand-for-change-in-healthcare-policy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.100141","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}